Gene expression analysis of blastemal component reveals genes associated with relapse mechanism in Wilms tumour

European Journal of Cancer

Volumn 47, Issue 18, 2011, Pages 2715-2722

  Maschietto, Mariana ^a,c   Piccoli, Fabio S ^a,c   Costa, Cecilia M L ^a   Camargo, Luiz P ^a   Neves, Jose I ^a   Grundy, Paul E ^b   Brentani, Helena ^a,c   Soares, Fernando A ^b,c   Camargo, Beatriz De ^c   Carraro, Dirce M ^a,c  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b STOLLERY CHILDREN S HOSPITAL   (Canada)

^c Fundaão Antônio Prudente ^*  (Brazil)

Author keywords

Blastemal component; Kidney; MCM2; Molecular marker; NCOA6; Relapse; Wilms tumour

Indexed keywords

COMPLEMENTARY DNA; MOLECULAR MARKER;

ARTICLE; BLASTEMA; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RELAPSE; CANCER STAGING; CHILD; CONTROLLED STUDY; DOWN REGULATION; DRUG METABOLISM; EMBRYO CELL; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NEPHROBLASTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD;

ADOLESCENT; CELL CYCLE PROTEINS; CHILD; CHILD, PRESCHOOL; DNA METHYLATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INFANT; KIDNEY NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; NUCLEAR PROTEINS; WILMS TUMOR;

EID: 82255162975     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.05.024     Document Type: Article

References (32)

1. Wilms' tumour: status report, 1990. By the National Wilms' Tumour Study Committee. J Clin Oncol 1991;9(5):877-87.
2. E.J. Perlman Pediatric renal tumors: practical updates for the pathologist Pediatr Dev Pathol 8 3 2005 320 338 (Pubitemid 41204479)
3. G.W. Mierau, J.B. Beckwith, and D.A. Weeks Ultrastructure and histogenesis of the renal tumors of childhood: an overview Ultrastruct Pathol 11 2-3 1987 313 333 (Pubitemid 17076968)
4. D.M. Green The treatment of stages I-IV favorable histology Wilms' tumor J Clin Oncol 22 8 2004 1366 1372 (Pubitemid 41103617)
5. A. Weirich, I. Leuschner, and D. Harms Clinical impact of histologic subtypes in localized non-anaplastic nephroblastoma treated according to the trial and study SIOP-9/GPOH Ann Oncol 12 3 2001 311 319 (Pubitemid 32288685)
6. J.A. Kalapurakal, J.S. Dome, and E.J. Perlman Management of Wilms' tumour: current practice and future goals Lancet Oncol 5 1 2004 37 46 (Pubitemid 38072558)
7. P. Grundy, N. Breslow, and D.M. Green Prognostic factors for children with recurrent Wilms' tumor: results from the Second and Third National Wilms' Tumor Study J Clin Oncol 7 5 1989 638 647 (Pubitemid 19126801)
8. J.S. Dome, T. Liu, and M. Krasin Improved survival for patients with recurrent Wilms tumor: the experience at St. Jude Children's Research Hospital J Pediatr Hematol Oncol 24 3 2002 192 198 (Pubitemid 34297562)
9. M. Malogolowkin, C.A. Cotton, and D.M. Green Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group Pediatr Blood Cancer 50 2 2008 236 241
10. D.M. Green, C.A. Cotton, and M. Malogolowkin Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group Pediatr Blood Cancer 48 5 2007 493 499 (Pubitemid 46496341)
11. M. Takahashi, X.J. Yang, and T.T. Lavery Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features Cancer Res 62 22 2002 6598 6605 (Pubitemid 35364126)
12. R.D. Williams, S.N. Hing, and B.T. Greer Prognostic classification of relapsing favorable histology Wilms tumor using cDNA microarray expression profiling and support vector machines Genes Chromosomes Cancer 41 1 2004 65 79 (Pubitemid 38988739)
13. C.C. Huang, S. Gadd, and N. Breslow Predicting relapse in favorable histology Wilms tumor using gene expression analysis: a report from the Renal Tumor Committee of the Children's Oncology Group Clin Cancer Res 15 5 2009 1770 1778
14. P.E. Grundy, N.E. Breslow, and S. Li Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group J Clin Oncol 23 29 2005 7312 7321 (Pubitemid 46205952)
15. B. Messahel, R. Williams, and A. Ridolfi Allele loss at 16q defines poorer prognosis Wilms tumour irrespective of treatment approach in the UKW1-3 clinical trials: a Children's Cancer and Leukaemia Group (CCLG) Study Eur J Cancer 45 5 2009 819 826
16. B. Zirn, O. Hartmann, and B. Samans Expression profiling of Wilms tumors reveals new candidate genes for different clinical parameters Int J Cancer 118 8 2006 1954 1962
17. M. Maschietto, B. de Camargo, and H. Brentani Molecular profiling of isolated histological components of Wilms tumor implicates a common role for the Wnt signaling pathway in kidney and tumor development Oncology 75 1-2 2008 81 91
18. R.R. Brentani, D.M. Carraro, and S. Verjovski-Almeida Gene expression arrays in cancer research: methods and applications Crit Rev Oncol Hematol 54 2 2005 95 105 (Pubitemid 40544947)
19. B.P. Mello, E.F. Abrantes, C.H. Torres, and A. Machado-Lima No-match ORESTES explored as tumor markers Nucleic Acids Res 37 8 2009 2607 2617
20. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002;3(7): RESEARCH0034.
21. A.I. Saeed, V. Sharov, and J. White TM4: a free, open-source system for microarray data management and analysis Biotechniques 34 2 2003 374 378 (Pubitemid 36184095)
22. G. Dennis, B.T. Sherman, and D.A. Hosack DAVID: Database for Annotation, Visualization, and Integrated Discovery Genome Biol 4 5 2003 P3
23. M.W. Pfaffl A new mathematical model for relative quantification in real-time RT-PCR Nucleic Acids Res 29 9 2001 e45
24. R. Natrajan, S.E. Little, and N. Sodha Analysis by array CGH of genomic changes associated with the progression or relapse of Wilms' tumour J Pathol 211 1 2007 52 59 (Pubitemid 46092029)
25. F. Spreafico, K. Pritchard Jones, and M.H. Malogolowkin Treatment of relapsed Wilms tumors: lessons learned Expert Rev Anticancer Ther 9 12 2009 1807 1815
26. S. Wittmann, C. Wunder, and B. Zirn New prognostic markers revealed by evaluation of genes correlated with clinical parameters in Wilms tumors Genes Chromosomes Cancer 47 5 2008 386 395 (Pubitemid 351451793)
27. W. Li, P. Kessler, and H. Yeger A gene expression signature for relapse of primary wilms tumors Cancer Res 65 7 2005 2592 2601 (Pubitemid 40490057)
28. M.A. Mahajan, and H.H. Samuels Nuclear receptor coactivator/coregulator NCoA6(NRC) is a pleiotropic coregulator involved in transcription, cell survival, growth and development Nucl Recept Signal 6 2008 e002
29. D. Dietrich, M. Krispin, and J. Dietrich BMC Cancer 10 2010 247
30. K. Rodins, M. Cheale, N. Coleman, and S.B. Fox Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility Clin Cancer Res 8 4 2002 1075 1081 (Pubitemid 35177358)
31. T.J. Dudderidge, K. Stoeber, and M. Loddo Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma Clin Cancer Res 11 7 2005 2510 2517 (Pubitemid 40569447)
32. A. Freeman, L.S. Morris, and A.D. Mills Minichromosome maintenance proteins as biological markers of dysplasia and malignancy Clin Cancer Res 5 8 1999 2121 2132 (Pubitemid 29399268)